On March 13, 2023 Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), reported that it plans to report its fourth quarter and year ended 2022 financial results after market close on Wednesday March 15, 2023 (Press release, Liminal BioSciences, MAR 13, 2023, View Source,-2023 [SID1234628599]). Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Thursday March 16, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To join the conference call without operator assistance, you may register and enter your phone number at https://bit.ly/3FeNJBk to receive an instant automated call back. You can also dial direct to be entered to the call by an Operator by dialing 416-764-8609 and 888-390-0605, using the following passcode: 77593817. An audio replay of the call will be available as of Thursday March 16, 2023 at 11:30 am (ET). The numbers to access the audio replay are 416-764-8677 and 1-888-390-0541 using the following password (593817 #). A live audio webcast of the conference call will be available by clicking here.